V. Rovei

发表

Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man

A. Eschalier, É. Zarifian, M. Strolin Benedetti, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency

G. Houin, J. Dueymes, V. Rovei, 2004, European Journal of Clinical Pharmacology.

Determination of low plasma concentrations of 3-methoxy-4-hydroxyphenylethylene glycol using gas chromatography-negative-ion chemical ionization mass spectrometry.

M. Strolin Benedetti, S. Vajta, V. Rovei, 1985, Journal of chromatography.

Determination of antipyrine sulphoconjugates in isolated cultured rat hepatocytes.

C. Advenier, V. Rovei, C. Palette, 1993, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase‐A inhibitor, and oral tyramine in healthy subjects

C. Funck-Brentano, P. Jaillon, J. Provost, 1992, Clinical pharmacology and therapeutics.

THE DRAMBALLET STUDIO

O. Curet, V. Rovei, N. Sontag, 1996 .

Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile.

O. Curet, V. Rovei, N. Sontag, 1996, The Journal of pharmacology and experimental therapeutics.

Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.

O. Bergis, C. Fankhauser, A. Grosset, 1996, The Journal of pharmacology and experimental therapeutics.

Plasma levels and clinical effects of antiepileptic drugs in pregnant epileptic patients and their newborns.

G. Avanzini, R. Spreafico, S. Franceschetti, 1980, Obstetrical and Gynecological Survey.

Gas chromatographic method for the determination of nomifensine in human plasma.

G. Bianchetti, L. Vereczkey, A. Frigerio, 1976, Journal of chromatography.

Pharmacokinetics and metabolism of the anti-arrhythmic carocainide in man.

M. Strolin Benedetti, A. Donath, C. Daniel, 1985, Xenobiotica; the fate of foreign compounds in biological systems.

Interaction of MAO inhibitors and dietary tyramine: a new experimental model in the conscious rat.

C. Fankhauser, V. Rovei, D. Caille, 1994, Journal of pharmacological and toxicological methods.

Biochemical pharmacology of befloxatone (MD370503), a new potent reversible MAO-A inhibitor.

O. Curet, V. Rovei, D. Caille, 1994, Journal of neural transmission. Supplementum.

Determination of antrafenine and its main acid metabolite, 2-{[7-(trifluoromethyl)-4-quinolinyl]amino}-benzoic acid, in biological fluids using high-performance liquid chromatography with large volume automatic injection and gas-liquid chromatography with derivative formation.

R. Braithwaite, V. Rovei, P. Guinebault, 1981, Journal of chromatography.

Simple and Specific High Performance Liquid Chromatographic Method for the Routine Monitoring of Clonazepam in Plasma

V. Rovei, M. Sanjuan, 1980, Therapeutic drug monitoring.

Pharmacokinetics and metabolism of diltiazem in man.

R. Gomeni, P. Morselli, V. Rovei, 1980, Acta cardiologica.

Quantitative determination of naproxen in plasma by a simple high-performance liquid chromatographic method.

R. Braithwaite, V. Rovei, M. Broquaire, 1981, Journal of chromatography.

Gas--liquid chromatographic determination of toloxatone in human plasma. Routine analysis of a wide range of drug concentrations using a nitrogen-selective detector.

S. Vajta, V. Rovei, J. le Moing, 1983, Journal of Chromatography A.

Placental transfer of pethidine and norpethidine and their pharmacokinetics in the newborn

P. Morselli, V. Rovei, 1980, European Journal of Clinical Pharmacology.

Determination of tolazoline in plasma by high-performance liquid chromatography.

P. Morselli, J. Thénot, V. Rovei, 1982, Journal of chromatography.

Identification of Cyclobenzaprine-10, 11-Epoxide and other Metabolites after Incubation of Cyclobenzaprine with Rat Liver Microsomes

A. Frigerio, G. Belvedere, V. Rovei, 1975 .

33. Brain Levels of Antiepileptic Drugs in Man

J. Talairach, J. Bancaud, M. Peschanski, 1980 .

Analysis of tricyclic antidepressant drugs by gas chromatography using nitrogen-selective detection with packed and capillary columns.

P. Hrdina, V. Rovei, M. Sanjuan, 1980, Journal of chromatography.

PHARMACOKINETICS OF DEXTROMORAMIDE IN SURGICAL PATIENTS

E. Perucca, N. Barzaghi, F. Crema, 1988, Fundamental & clinical pharmacology.

Mass spectrometric identification of an N-oxide formed by incubation of N,N-dimethyl-5H-dibenzo[a,d]cycloheptene-Δ5,γ-propylamine with rat liver microsomes

A. Frigerio, G. Belvedere, V. Rovei, 1974 .

Pharmacokinetics of theophylline: a dose-range study.

M. Strolin Benedetti, M Strolin Benedetti, V Rovei, 1982, British journal of clinical pharmacology.

Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderly

R. Gomeni, P. Morselli, P. Hrdina, 2004, Psychopharmacology.

The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosis

G. Houin, J. Escourrou, V. Rovei, 2004, European Journal of Clinical Pharmacology.

Can a 1,2-oxygen shift of a nicotinamide N-oxide derivative occur in vivo?

M. Strolin Benedetti, P. Dostert, V. Rovei, 1985, Xenobiotica; the fate of foreign compounds in biological systems.

Mass spectrometric studies of the metabolites of niaprazine

J. Dow, M. Benedetti, V. Rovei, 1983 .

Long-Term Monitoring of Tricyclic Antidepressant Plasma Concentrations

P. Morselli, C. Altamura, V. Rovei, 1980, British Journal of Psychiatry.

Pharmacokinetics of Pethidine in Women in Labour and in the Newborn

G. Barrier, P. Morselli, V. Rovei, 1981 .